These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 36566428)
1. Restarting Antiplatelet Agents After Intracerebral Haemorrhage: A Reassurance To Physicians. Aemaz-Ur-Rehman M; Farooq H; Ebaad Ur Rehman M J Ayub Med Coll Abbottabad; 2022; 34(4):907. PubMed ID: 36566428 [No Abstract] [Full Text] [Related]
2. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial. van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ; Trials; 2015 Sep; 16():393. PubMed ID: 26340977 [TBL] [Abstract][Full Text] [Related]
14. The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial. Al-Shahi Salman R; Murray GD; Dennis MS; Newby DE; Sandercock PAG; Sprigg N; Sudlow CLM; Werring DJ; White PM; Whiteley WN Trials; 2019 Mar; 20(1):183. PubMed ID: 30909946 [TBL] [Abstract][Full Text] [Related]
15. Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial. Schreuder FHBM; van Nieuwenhuizen KM; Hofmeijer J; Vermeer SE; Kerkhoff H; Zock E; Luijckx GJ; Messchendorp GP; van Tuijl J; Bienfait HP; Booij SJ; van den Wijngaard IR; Remmers MJM; Schreuder AHCML; Dippel DW; Staals J; Brouwers PJAM; Wermer MJH; Coutinho JM; Kwa VIH; van Gelder IC; Schutgens REG; Zweedijk B; Algra A; van Dalen JW; Jaap Kappelle L; Rinkel GJE; van der Worp HB; Klijn CJM; Lancet Neurol; 2021 Nov; 20(11):907-916. PubMed ID: 34687635 [TBL] [Abstract][Full Text] [Related]
16. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke. Lapchak PA; Araujo DM; Song D; Zivin JA Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904 [TBL] [Abstract][Full Text] [Related]
17. Early Administration of Desmopressin and Platelet Transfusion for Reducing Hematoma Expansion in Patients With Acute Antiplatelet Therapy Associated Intracerebral Hemorrhage. Mengel A; Stefanou MI; Hadaschik KA; Wolf M; Stadler V; Poli K; Lindig T; Ernemann U; Grimm F; Tatagiba M; Ziemann U; Poli S Crit Care Med; 2020 Jul; 48(7):1009-1017. PubMed ID: 32304415 [TBL] [Abstract][Full Text] [Related]
18. Antithrombotic therapy in patients with any form of intracranial haemorrhage: a systematic review of the available controlled studies. Keir SL; Wardlaw JM; Sandercock PA; Chen Z Cerebrovasc Dis; 2002; 14(3-4):197-206. PubMed ID: 12403952 [TBL] [Abstract][Full Text] [Related]
19. Antiplatelet Therapy after Intracerebral Hemorrhage and Subsequent Clinical Events: A 12-Year South Korean Cohort Study. Moon JY; Lee JG; Kim JH Eur Neurol; 2021; 84(3):183-191. PubMed ID: 33831859 [TBL] [Abstract][Full Text] [Related]
20. Antithrombotic treatment and intracerebral haemorrhage: between Scylla and Charybdis. Hofmeijer J; Kappelle LJ; Klijn CJ Pract Neurol; 2015 Aug; 15(4):250-6. PubMed ID: 25922539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]